Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 704.47 -0.53%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Regeneron Pharmaceuticals Operating Cash Flow 2011-2024 | REGN

Annual Operating Cash Flow Regeneron Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.59 B 5.01 B 7.08 B 2.62 B 2.43 B 2.2 B 1.31 B 1.49 B 1.33 B 752 M 589 M -74.6 M -142 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
7.08 B -142 M 2.24 B

Quarterly Operating Cash Flow Regeneron Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 1.51 B - - 1.37 B - 3.3 B - 2.1 B - 4.71 B - 668 M - 1.39 B 1.64 B 698 M - 1.64 B 1.09 B 897 M - 1.47 B 1.01 B 619 M - 740 M 325 M 356 M - 1.1 B 444 M 45 M - 1.05 B 156 M -102 M - 554 M 390 M 53.5 M - 307 M 214 M 86.2 M - -168 M -165 M -87 M - -91.4 M -44.6 M -10.6 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
4.71 B -168 M 813 M